1. Home
  2. HROW vs IMKTA Comparison

HROW vs IMKTA Comparison

Compare HROW & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HROW

Harrow Inc.

HOLD

Current Price

$39.48

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Ingles Markets Incorporated

IMKTA

Ingles Markets Incorporated

HOLD

Current Price

$86.52

Market Cap

1.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
HROW
IMKTA
Founded
1998
1963
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Food Chains
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2008
1994

Fundamental Metrics

Financial Performance
Metric
HROW
IMKTA
Price
$39.48
$86.52
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$69.86
N/A
AVG Volume (30 Days)
550.4K
110.0K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
0.74%
EPS Growth
71.43
N/A
EPS
N/A
N/A
Revenue
N/A
$5,334,032,609.00
Revenue This Year
$31.62
N/A
Revenue Next Year
$50.77
N/A
P/E Ratio
N/A
$15.91
Revenue Growth
N/A
N/A
52 Week Low
$28.54
$63.75
52 Week High
$54.98
$95.62

Technical Indicators

Market Signals
Indicator
HROW
IMKTA
Relative Strength Index (RSI) 49.09 45.08
Support Level $37.03 $86.26
Resistance Level $41.82 $91.00
Average True Range (ATR) 1.80 2.79
MACD -0.00 -0.18
Stochastic Oscillator 49.15 28.99

Price Performance

Historical Comparison
HROW
IMKTA

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

Share on Social Networks: